These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1428366)

  • 21. [A comparative study of the expression of activation markers on T-lymphocyte subpopulations in different forms of bronchial asthma].
    Beda MV; Pavliuk AS; Veselova AV; Dement'eva EG; Solov'ev SS; Bart BIa; Koval'chuk LV
    Ter Arkh; 1995; 67(3):26-9. PubMed ID: 7770797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporin A does not inhibit the PHA-stimulated increase in intracellular Ca2+ concentration but inhibits the increase in E-rosette receptor (CD2) expression and appearance of interleukin-2 receptors (CD25).
    Redelman D
    Cytometry; 1988 Mar; 9(2):156-63. PubMed ID: 2896111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial mastocytosis: a clinical, immunophenotypic, light and electron microscopic study.
    Anstey A; Lowe DG; Kirby JD; Horton MA
    Br J Dermatol; 1991 Dec; 125(6):583-7. PubMed ID: 1836952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of human CD4+CD45RA+ T cells by chrysotile asbestos in vitro.
    Kinugawa K; Ueki A; Yamaguchi M; Watanabe Y; Kawakami Y; Hyodoh F; Tsushima H
    Cancer Lett; 1992 Sep; 66(2):99-106. PubMed ID: 1382835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mildly oxidized low-density lipoproteins suppress the proliferation of activated CD4+ T-lymphocytes and their interleukin 2 receptor expression in vitro.
    Caspar-Bauguil S; Saadawi M; Negre-Salvayre A; Thomsen M; Salvayre R; Benoist H
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):659-66. PubMed ID: 9480872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoregulation of lymphoproliferation in vitro by monocytes and their subpopulations. II. Phenotypic changes of T cells in cultures activated with antigen and mitogen.
    Pryjma J; Kowalczyk D; Ruggiero I; Zembala M
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):139-43. PubMed ID: 1363714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A short incubation with PGE2 affects the proliferative response of T lymphocytes to PWM.
    Santarpia G; Valenti A; Loteta L; Sofo V; Sottile A; Serrao N; Salmeri FM; Teti D
    Immunopharmacol Immunotoxicol; 1992; 14(4):757-67. PubMed ID: 1294621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating activated T lymphocytes in autoeczematization.
    Kasteler JS; Petersen MJ; Vance JE; Zone JJ
    Arch Dermatol; 1992 Jun; 128(6):795-8. PubMed ID: 1599265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of activation surface markers, interleukin-2 synthesis and apoptosis rate in fresh or cultured lymphocytes from HIV-infected children.
    Voiculescu C; Avramescu C; Radu E; Bălăşoiu M; Turculeanu A
    Roum Arch Microbiol Immunol; 1998; 57(1):33-44. PubMed ID: 9745333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The expression of activation markers on decidual lymphocytes in the first trimester of pregnancy].
    Slukvin II; Chernyshov VP; Merkulova AV
    Biull Eksp Biol Med; 1993 Oct; 116(10):414-6. PubMed ID: 8117970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro ozone exposure inhibits mitogen-induced lymphocyte proliferation and IL-2 production.
    Becker S; Jordan RL; Orlando GS; Koren HS
    J Toxicol Environ Health; 1989; 26(4):469-83. PubMed ID: 2785216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.
    Lombardi VR; García M; Rey L; Cacabelos R
    J Neuroimmunol; 1999 Jun; 97(1-2):163-71. PubMed ID: 10408971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.
    Gummert JF; Barten MJ; Sherwood SW; van Gelder T; Morris RE
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1100-12. PubMed ID: 10565830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of lymphocyte activation by flow cytometric determination of interleukin-2 (CD25) receptor.
    Santos JL; Montes MJ; Garcia-Pacheco M; Gonzalez MR; Gutierrez F
    J Clin Lab Immunol; 1991 Mar; 34(3):145-9. PubMed ID: 1667947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression.
    Lin RY; Astiz ME; Saxon JC; Rackow EC
    Chest; 1993 Sep; 104(3):847-53. PubMed ID: 7689946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allergen-induced expression of cell surface markers on lymphocytes of Chi t I-sensitized patients.
    Liebers V; Raulf M; Baur X
    Allergy; 1994 Mar; 49(3):163-9. PubMed ID: 8198248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of in vivo and in vitro methotrexate on lymphocyte proliferation as measured by the uptake of tritiated thymidine and tritiated guanosine.
    Johnston C; Russell AS; Aaron S
    Clin Exp Rheumatol; 1988; 6(4):391-3. PubMed ID: 3229029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anchored anti-HLA class I monoclonal antibody fails to induce inhibition of PHA-activated lymphocytes proliferation.
    Rubini M; Selvatici R; Orlando P; Balboni A; Boninsegna S; Gandini E
    Biochem Biophys Res Commun; 1992 Oct; 188(1):278-85. PubMed ID: 1417848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis.
    Cush JJ; Lipsky PE
    Arthritis Rheum; 1988 Oct; 31(10):1230-8. PubMed ID: 3263133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.